Please login to the form below

Not currently logged in
Email:
Password:

Porter Novelli appoints Sally Ward as MD

PR agency Porter Novelli has appointed Sally Ward as partner and managing director of its operations in the UK

PR agency Porter Novelli has appointed Sally Ward as partner and managing director of its operations in the UK. Ward replaces Jean Wyllie, who announced her departure from the agency late last year.

Ward was previously founder and director of Plum Consulting, an executive search, talent management and senior-level coaching and mentoring firm. Prior to this she spent five years with Weber Shandwick UK; and before then seven years with Porter Novelli (known then as Countrywide Porter Novelli) as a portfolio director and later as the agency's UK development director.

 

Sally Ward
Sally Ward

 

"We are delighted to welcome Sally back to the agency," said Gary Stockman, CEO, Porter Novelli. "She is an extremely well-respected leader in the industry with a 20-year track record of growing business both domestically and across borders. Her emphasis and personal commitment to attracting and developing talent will be especially valuable."

Ward said: "Taking on this role was a challenge that I couldn't resist. Porter Novelli remains a strong brand synonymous with quality work, and I look forward to helping to grow its position in the marketplace. Addressing that will be exciting, as will the opportunity to build an industry-leading team."

In addition to her roles as UK MD and partner, Ward will join Porter Novelli's executive committee.
 

28th January 2010

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
11 London

We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...

Latest intelligence

Main image2
Customers, content and change
By Dominic Tyer...
Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...